Last reviewed · How we verify
Aluminum Chloride (aluminium chloride)
At a glance
| Generic name | aluminium chloride |
|---|---|
| Drug class | aluminium chloride |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Approved indications
- Hyperhidrosis
Common side effects
Drug interactions
- levothyroxine sodium
- moxifloxacin
Key clinical trials
- Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults (PHASE1)
- A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes (PHASE1)
- Safety and Efficacy of wSp Vaccine in Young Children (PHASE2)
- Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals. (NA)
- Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy (PHASE1)
- TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus (PHASE2)
- Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda (PHASE2)
- Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aluminum Chloride CI brief — competitive landscape report
- Aluminum Chloride updates RSS · CI watch RSS
- portfolio CI